2020 Annual Meeting | C57 - Neuromuscular Junction Disorders 1: Myasthenia Gravis, Ocular, and MuSK Myasthenia

Date Sunday 04/26/20

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Srikanth Muppidi, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders, learn to critically select appropriate therapies, and be able to distinguish myasthenia gravis, MuSK myasthenia, and less common disorders of neuromuscular junction dysfunction including Lambert-Eaton syndrome, and other disorders of neuromuscular junction dysfunction.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:50 PM	Speaker	AChR+Ve Generalized MG, Diagnosis, and Treatments: Current Therapies and Future Directions Srikanth Muppidi, MD, FAAN
01:50 PM - 02:00 PM	Q&A	Questions and Answers Srikanth Muppidi, MD, FAAN
02:00 PM - 02:50 PM	Speaker	Ocular, Seronegative, and MuSK MG: Diagnosis and Treatment Options Amanda C. Guidon, MD, MPH
02:50 PM - 03:00 PM	Q&A	Questions and Answers Amanda C. Guidon, MD, MPH

Faculty Disclosures
Srikanth Muppidi, MD, FAAN	Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. muppidi has received publishing royalties from a publication relating to health care.
Amanda C. Guidon, MD, MPH	An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Guidon has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Guidon has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill. The institution of Dr. Guidon has received research support from NINDS. The institution of Dr. Guidon has received research support from Biosensics. Dr. Guidon has received publishing royalties from a publication relating to health care. Dr. Guidon has a non-compensated relationship as a Committee Member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities.

��ɫ��

��ɫ��